Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Zepbound (tirzepatide for weight management) Zepbound received FDA approval in November 2023 for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition
Funding This work was supported by the University of Zagreb, Zagreb, Croatia (Grant BM 099)
37 : Iss
It is recommended to frequently monitor blood levels of potassium and platelet counts in these individuals for early detection and appropriate management of any abnormalities
some advance to 2.0 mg if HbA1c targets arent met
US$ 29.83
US$ 24.89
US$ 27.16
US$ 24.92
US$ 23.60
US$ 23.14
US$ 26.73
